The Keytruda biosimilars are coming. In October, the FDA accepted the first publicly announced application for a Keytruda copycat dubbed FYB206, which it could approve as early as the third quarter of ...
America's leading pharma trade group is suing the Trump administration over drug pricing policies. On Oct. 7, the Pharmaceutical Research and Manufacturers of America, or PhRMA, challenged a new ...
When Stacy Hurt looks at a clinical trial protocol, she’s always thinking about something beyond its endpoints — her 21-year-old son Emmett. Diagnosed with a chromosome abnormality so rare that his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results